HydRegen secures $8 million (£6 million) in Series A funding to develop enzyme-based catalysts for industrial chemical production. The biotechnology platform replaces traditional precious-metal catalysts, aiming to integrate with existing manufacturing systems. This approach targets cost reduction and sustainability in chemical manufacturing processes.
Zymofix is constructing a flagship manufacturing plant in Deinze, Belgium, to scale its **Zyft** solid-state fermentation platform for industrial production. The company secured funding in a **Series A round led by First Imagine!**, with participation from existing investors including **VP Capital, HTGF, and The Nest Family Office**. This expansion follows successful pilot operations and marks a key milestone in transitioning from lab-scale to large-scale microbial manufacturing.
First Imagine!
First Imagine! invests venture capital in technologies for resilience, autonomy and productivity.